Metabolic dependency of non-small cell lung cancer cells affected by three-dimensional scaffold and its stiffness

被引:2
|
作者
Fu, Xiaorong [1 ]
Kimura, Yasuhiro [1 ]
Toku, Yuhki [1 ]
Song, Guanbin [2 ]
Ju, Yang [1 ]
机构
[1] Nagoya Univ, Grad Sch Engn, Dept Micronano Mech Sci & Engn, Nagoya, Aichi, Japan
[2] Chongqing Univ, Coll Bioengn, Key Lab Biorheol Sci & Technol, Minist Educ, Chongqing 400030, Peoples R China
关键词
Extracellular matrix; Collagen-chitosan scaffolds; Stiffness; Metabolic phenotypes; Non-small cell lung cancer cells; Glycolysis; Mitochondrial metabolism; FATTY-ACID-METABOLISM; MECHANISMS; CHITOSAN; MICROENVIRONMENT; PROLIFERATION; BIOMATERIALS; METASTASIS; RESISTANCE;
D O I
10.1007/s13105-023-00960-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Three-dimensional (3D) extracellular matrix (ECM) microenvironment is an important regulator of the stiffness of the tumors. Cancer cells require heterogeneous metabolic phenotypes to cope with resistance in the malignant process. However, how the stiffness of the matrix affects the metabolic phenotypes of cancer cells, is lacking. In this study, the young's modulus of the synthesized collagen-chitosan scaffolds was adjusted according to the percentage ratio of collagen to chitosan. We cultured non-small cell lung cancer (NSCLC) cells in four different microenvironments (two-dimensional (2D) plates, stiffest 0.5-0.5 porous collagen-chitosan scaffolds, middle stiff 0.5-1 porous collagen-chitosan scaffolds, and softest 0.5-2 porous collagen-chitosan scaffolds) to investigate the influence of the difference of 2D and 3D cultures as well as the 3D scaffolds with different stiffnesses on the metabolic dependency of NSCLC cells. The results revealed that NSCLC cells cultured in 3D collagen-chitosan scaffolds displayed higher capacity of mitochondrial metabolism and fatty acid metabolism than that cultured in 2D culture. The metabolic response of NSCLC cells is differential for 3D scaffolds with different stiffnesses. The cells cultured in middle stiff 0.5-1 scaffolds displayed a higher potential of mitochondrial metabolism than that of stiffer 0.5-0.5 scaffolds and softer 0.5-2 scaffolds. Furthermore, NSCLC cells culture in 3D scaffolds displayed drug resistance compared with that in 2D culture which maybe via the hyperactivation of the mTOR pathway. Moreover, the cells cultured in 0.5-1 scaffolds showed higher ROS levels, which were counterbalanced by an equally high expression of antioxidant enzymes when compared to the cells grown in 2D culture, which may be regulated by the increased expression of PGC-1 alpha. Together, these results demonstrate that differences in the microenvironments of cancer cells profoundly impact their metabolic dependencies.
引用
收藏
页码:597 / 611
页数:15
相关论文
共 50 条
  • [1] Metabolic dependency of non-small cell lung cancer cells affected by three-dimensional scaffold and its stiffness
    Xiaorong Fu
    Yasuhiro Kimura
    Yuhki Toku
    Guanbin Song
    Yang Ju
    Journal of Physiology and Biochemistry, 2023, 79 : 597 - 611
  • [2] The impact of three-dimensional radiation on the treatment of non-small cell lung cancer
    Armstrong, J
    Mc Gibney, C
    RADIOTHERAPY AND ONCOLOGY, 2000, 56 (02) : 157 - 167
  • [3] Clinical Research on Three-Dimensional Conformal Radiotherapy of Non-Small Cell Lung Cancer
    Baolin Yuan Tao Zhang Jianqi Luo Liang Zhang Suqun Chen Lina Yang Yong Wu Yuying Ma Department of Radiation Oncology
    Chinese Journal of Clinical Oncology, 2008, (04) : 263 - 267
  • [4] Treatment outcomes of three-dimensional conformal radiotherapy for non-small cell lung cancer
    Cho, M
    Yeo, S
    Kim, K
    Kim, S
    Lim, S
    Kim, J
    LUNG CANCER, 2005, 49 : S305 - S305
  • [5] Three-dimensional conformal radiotherapy in the radical treatment of non-small cell lung cancer
    Wilson, EM
    CLINICAL ONCOLOGY, 2003, 15 (07) : 412 - 419
  • [6] Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer
    Armstrong, J
    Raben, A
    Zelefsky, M
    Burt, M
    Leibel, S
    Burman, C
    Kutcher, G
    Harrison, L
    Hahn, C
    Ginsberg, R
    Rusch, V
    Kris, M
    Fuks, Z
    RADIOTHERAPY AND ONCOLOGY, 1997, 44 (01) : 17 - 22
  • [7] Three-dimensional organoid model for acquired drug resistance in non-small cell lung cancer
    Shukla, Navika D.
    Salahudeen, Ameen A.
    Padda, Sukhmani K.
    Neal, Joel W.
    Wakelee, Heather A.
    Kuo, Calvin J.
    CLINICAL CANCER RESEARCH, 2018, 24 (17)
  • [8] Metabolic Diversity in Human Non-Small Cell Lung Cancer Cells
    Chen, Pei-Hsuan
    Cai, Ling
    Huffman, Kenneth
    Yang, Chendong
    Kim, Jiyeon
    Faubert, Brandon
    Boroughs, Lindsey
    Ko, Bookyung
    Sudderth, Jessica
    McMillan, Elizabeth A.
    Girard, Luc
    Chen, Dong
    Peyton, Michael
    Shields, Misty D.
    Yao, Bo
    Shames, David S.
    Kim, Hyun Seok
    Timmons, Brenda
    Sekine, Ikuo
    Britt, Rebecca
    Weber, Stephanie
    Byers, Lauren A.
    Heymach, John V.
    Chen, Jing
    White, Michael A.
    Minna, John D.
    Xiao, Guanghua
    DeBerardinis, Ralph J.
    MOLECULAR CELL, 2019, 76 (05) : 838 - +
  • [9] Mimicking Tumor Hypoxia in Non-Small Cell Lung Cancer Employing Three-Dimensional In Vitro Models
    Ziolkowska-Suchanek, Iwona
    CELLS, 2021, 10 (01) : 1 - 23
  • [10] Formulaic Approach to Treatment Planning of Non-small Cell Lung Cancer with Three-Dimensional Conformal Radiotherapy
    Zusag, Thomas
    Chen, Sea
    Kirk, Mike
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2008, 31 (06): : 620 - 620